These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 26580824)
1. Preparation of a novel starch-derived three-dimensional ordered macroporous carbon for improving the dissolution rate and oral bioavailability of water-insoluble drugs. Liu Y; Wu C; Hao Y; Xu J; Zhao Y; Qiu Y; Jiang J; Yu T; Ji P J Pharm Biomed Anal; 2016 Jan; 118():267-275. PubMed ID: 26580824 [TBL] [Abstract][Full Text] [Related]
2. Development of a novel starch with a three-dimensional ordered macroporous structure for improving the dissolution rate of felodipine. Hao Y; Wu C; Zhao Z; Zhao Y; Xu J; Qiu Y; Jiang J; Yu T; Ma C; Zhou B Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():1131-7. PubMed ID: 26478413 [TBL] [Abstract][Full Text] [Related]
3. Carboxylated mesoporous carbon microparticles as new approach to improve the oral bioavailability of poorly water-soluble carvedilol. Zhang Y; Zhi Z; Li X; Gao J; Song Y Int J Pharm; 2013 Sep; 454(1):403-11. PubMed ID: 23850816 [TBL] [Abstract][Full Text] [Related]
4. Increasing the dissolution rate and oral bioavailability of the poorly water-soluble drug valsartan using novel hierarchical porous carbon monoliths. Zhang Y; Che E; Zhang M; Sun B; Gao J; Han J; Song Y Int J Pharm; 2014 Oct; 473(1-2):375-83. PubMed ID: 25051114 [TBL] [Abstract][Full Text] [Related]
5. Biodegradable Porous Starch Spheres as a Novel Carrier for Enhancement of Dissolution Rate and Oral Bioavailability of Itraconazole. Pawar J; Ali MT; Fule R; Moravkar K; Seervi M; Sathaye S; Amin P Curr Drug Deliv; 2017; 14(7):944-954. PubMed ID: 27654575 [TBL] [Abstract][Full Text] [Related]
6. Formulation and optimization of drug-loaded mesoporous silica nanoparticle-based tablets to improve the dissolution rate of the poorly water-soluble drug silymarin. Ibrahim AH; Smått JH; Govardhanam NP; Ibrahim HM; Ismael HR; Afouna MI; Samy AM; Rosenholm JM Eur J Pharm Sci; 2020 Jan; 142():105103. PubMed ID: 31648050 [TBL] [Abstract][Full Text] [Related]
7. Preparation of a Mesoporous Structure of SnO Liu X; Wu C; Bai A; Lv H; Xu X; Cao Y; Shang W; Hu L; Liu Y AAPS PharmSciTech; 2018 Oct; 19(7):3228-3236. PubMed ID: 30187447 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of novel core-shell structured dual-mesoporous silica nanospheres and their application for enhancing the dissolution rate of poorly water-soluble drugs. Wu C; Sun X; Zhao Z; Zhao Y; Hao Y; Liu Y; Gao Y Mater Sci Eng C Mater Biol Appl; 2014 Nov; 44():262-7. PubMed ID: 25280705 [TBL] [Abstract][Full Text] [Related]
9. Ketoprofen mesoporous silica nanoparticles SBA-15 hard gelatin capsules: preparation and in vitro/in vivo characterization. Abd-Elrahman AA; El Nabarawi MA; Hassan DH; Taha AA Drug Deliv; 2016 Nov; 23(9):3387-3398. PubMed ID: 27167529 [TBL] [Abstract][Full Text] [Related]
10. Multilayer encapsulated mesoporous silica nanospheres as an oral sustained drug delivery system for the poorly water-soluble drug felodipine. Hu L; Sun H; Zhao Q; Han N; Bai L; Wang Y; Jiang T; Wang S Mater Sci Eng C Mater Biol Appl; 2015 Feb; 47():313-24. PubMed ID: 25492202 [TBL] [Abstract][Full Text] [Related]
11. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac. Kumar D; Sailaja Chirravuri SV; Shastri NR Int J Pharm; 2014 Jan; 461(1-2):459-68. PubMed ID: 24368106 [TBL] [Abstract][Full Text] [Related]
12. Development of a tin oxide carrier with mesoporous structure for improving the dissolution rate and oral relative bioavailability of fenofibrate. Bai A; Wu C; Liu X; Lv H; Xu X; Cao Y; Shang W; Hu L; Liu Y Drug Des Devel Ther; 2018; 12():2129-2138. PubMed ID: 30022811 [TBL] [Abstract][Full Text] [Related]
13. Development of biodegradable porous starch foam for improving oral delivery of poorly water soluble drugs. Wu C; Wang Z; Zhi Z; Jiang T; Zhang J; Wang S Int J Pharm; 2011 Jan; 403(1-2):162-9. PubMed ID: 20937370 [TBL] [Abstract][Full Text] [Related]
14. Exploitation of 3D face-centered cubic mesoporous silica as a carrier for a poorly water soluble drug: influence of pore size on release rate. Zhu W; Wan L; Zhang C; Gao Y; Zheng X; Jiang T; Wang S Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():78-85. PubMed ID: 24268236 [TBL] [Abstract][Full Text] [Related]
15. Development of novel core-shell dual-mesoporous silica nanoparticles for the production of high bioavailable controlled-release fenofibrate tablets. Zhao Z; Gao Y; Wu C; Hao Y; Zhao Y; Xu J Drug Dev Ind Pharm; 2016; 42(2):199-208. PubMed ID: 26114553 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of mesoporous carbon/lipid bilayer nanocomposites for improved oral delivery of the poorly water-soluble drug, nimodipine. Zhang Y; Zhao Q; Zhu W; Zhang L; Han J; Lin Q; Ai F Pharm Res; 2015 Jul; 32(7):2372-83. PubMed ID: 25609013 [TBL] [Abstract][Full Text] [Related]
17. Optimization of mirtazapine loaded into mesoporous silica nanostructures via Box-Behnken design: Musallam AA; Mahdy MA; Elnahas HM; Aldeeb RA Drug Deliv; 2022 Dec; 29(1):1582-1594. PubMed ID: 35612286 [TBL] [Abstract][Full Text] [Related]
18. Preparation of starch macrocellular foam for increasing the dissolution rate of poorly water-soluble drugs. Zhao Y; Wu C; Zhao Z; Hao Y; Xu J; Yu T; Qiu Y; Jiang J Pharm Dev Technol; 2016 Sep; 21(6):749-54. PubMed ID: 26166407 [TBL] [Abstract][Full Text] [Related]
19. Biomimetic synthesis and evaluation of histidine-derivative templated chiral mesoporous silica for improved oral delivery of the poorly water-soluble drug, nimodipine. Li H; Li H; Wei C; Ke J; Li J; Xu L; Liu H; YangYang ; Li S; Yang M Eur J Pharm Sci; 2018 May; 117():321-330. PubMed ID: 29530545 [TBL] [Abstract][Full Text] [Related]
20. In vivo evaluation of modified gum karaya as a carrier for improving the oral bioavailability of a poorly water-soluble drug, nimodipine. Murali Mohan Babu GV; Kumar NR; Sankar KH; Ram BJ; Kumar NK; Murthy KV AAPS PharmSciTech; 2002; 3(2):E12. PubMed ID: 12916949 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]